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The interaction between 
Staphylococcus aureus SdrD and 
desmoglein 1 is important for 
adhesion to host cells
Fatemeh Askarian1, Clement Ajayi1, Anne-Merethe Hanssen1, Nina M. van Sorge2, 
Ingvild Pettersen1, Dzung B. Diep3, Johanna U. E. Sollid1 & Mona Johannessen1
Staphylococcus aureus is known as a frequent colonizer of the skin and mucosa. Among bacterial factors 
involved in colonization are adhesins such as the microbial surface components recognizing adhesive 
matrix molecules (MSCRAMMs). Serine aspartate repeat containing protein D (SdrD) is involved in 
adhesion to human squamous cells isolated from the nose. Here, we identify Desmoglein 1 (Dsg1) 
as a novel interaction partner for SdrD. Genetic deletion of sdrD in S. aureus NCTC8325-4 through 
allelic replacement resulted in decreased bacterial adherence to Dsg1- expressing HaCaT cells in vitro. 
Complementary gain-of-function was demonstrated by heterologous expression of SdrD in Lactococcus 
lactis, which increased adherence to HaCaT cells. Also ectopic expression of Dsg1 in HEK293 cells 
resulted in increased adherence of S. aureus NCTC8325-4 in vitro. Increased adherence of NCTC8325-4, 
compared to NCTC8325-4ΔsdrD, to the recombinant immobilized Dsg1 demonstrated direct interaction 
between SdrD and Dsg1. Specificity of SdrD interaction with Dsg1 was further verified using flow 
cytometry and confirmed binding of recombinant SdrD to HaCaT cells expressing Dsg1 on their surface. 
These data demonstrate that Dsg1 is a host ligand for SdrD.
Staphylococcus aureus is a human commensal that frequently colonizes the human skin and mucosa, either for 
long or short periods throughout life1,2. It is also an important cause of several life-threatening infections. The 
ability of S. aureus to efficiently colonize the host epithelium, invade tissues and survive within host cells is regu-
lated through numerous adhesive and invasive factors3,4.
S. aureus expresses a panel of cell-wall anchored adhesins including the microbial surface components rec-
ognizing adhesive matrix molecule (MSCRAMM) families, which target extracellular matrix proteins and other 
molecules on host cells5–8. The Clumping factor (Clf) and Serine aspartate repeat containing protein (Sdr) fam-
ilies of MSCRAMMs share structural features. They contain N-terminal signal peptide followed by an A region 
(divided into distinct sub-domains called N1, N2 and N3), two to five B repeats, an R domain (Ser-Asp repeats), 
a LPXTG cell wall-anchoring motif, a hydrophobic membrane spanning region, and a cytoplasmic C-terminal 
end8,9 (Fig. 1a).
Bacteria can target intercellular junctions on host cells to promote adhesion and/or internalization during 
colonization and infection10–12. Desmosomes are the main type of adhesive disk shaped intercellular junctions, 
abundant in tissues exposed to mechanical stress, such as skin and heart13. The desmosomal cadherins, desmo-
gleins (Dsgs) consist of extracellular, transmembrane and cytoplasmic domains14. The extracellular domain is 
calcium-dependent and composed of 4 cadherin repeats (EC 1–4), and the extracellular anchor domain (EA), 
while the intracellular tail binds to adaptors connected to the intermediate filaments of host cytoskeleton15. The 
expression pattern of desmoglein isoforms 1–4 in human epidermis is highly variable16–18. These expression pat-
terns impact on the barrier function19 and also the differentiation of the epithelial tissues20.
Dsg1 is expressed throughout all the nucleated cell layers of human epidermis18 and recent evidence suggests 
that either Dsg1 or Dsg3 can compensate for the adhesive functions of each other in different epithelia tissues21,22. 
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Dsg1 has been shown to mediate keratinocyte differentiation in the epidermis23. In addition, Dsg1 plays a key role 
in the pathogenesis of three different dermatological conditions including; pemphigus foliaceus, staphylococcal 
scalded skin syndrome and striate palmoplantar keratoderma (reviewed in24). It has also been demonstrated that 
mutations in the dsg1 gene results in severe dermatitis, multiple allergies and metabolic wasting25.
The role of MSCRAMMs in S. aureus colonization and infection has been demonstrated previously (reviewed 
in8). Several of the MSCRAMMs are involved in attachment of S. aureus to squamous epithelial cells26–28 and 
keratinocytes29 in vitro as well as promoting nasal colonization in mice27,30 and humans31. SdrD specifically 
Figure 1. sdrD gene localization and expression in S. aureus NCTC8325-4. (a) Schematic representation of 
SdrD domain structure in S. aureus NCTC8325-4 based on UniProtKB. S, signal sequence; A region composed 
of N1, N2 and N3; B repeats composed of B1 to B5; SD, serine-aspartate acid repeat region; W, wall-spanning 
fragment; LPETG, cell wall anchoring motif; M, transmembrane domain; C, cytoplasmic domain. (b) sdrC and 
sdrD is located between ORFs encoding hypothetical proteins according to annotation is from KEGG Genome 
map. Gene and protein name based on UniProtKB: araB, ribonuclokinase; a: SAOUHSC_00536, Branched-
chain-amino-acid aminotransferase; b: SAOUHSC_00538, Haloacid dehalogenase-like hydrolase; sdrC, serine-
aspartate repeat-containing protein C; sdrD, serine-aspartate repeat-containing protein D; folE2, GTP 
cyclohydrolase FolE2; c: SAOUHSC_00554, SIS domain protein; d: SAOUHSC_00556, Proline/betaine 
transporter; e: SAOUHSC_00558, Acetyl-CoA acetyltransferase (c) Immunoblot using SdrD A-region and 
GroL antibodies on cell lysate S. aureus NCTC8325-4 or its isogenic mutant NCTC8325-4ΔsdrD and L.lactis 
with pMG36e-SdrD (SdrD) or pMG36e (empty vector). (d) sdrD promoter activity in DMEM supplemented 
with FBS without agitation in the absence ( ) or presence (◾) of HaCaT cells using S. aureus NCTC8325-4 
harbouring sdrD-GFP reporter construct. Data expressed as mean ± standard deviation (SD) of an individual 
experiment.
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promotes adherence of bacteria to desquamated nasal epithelial cells, harvested from human donors26. Thus, we 
hypothesize that SdrD may promote colonization through interaction with particular host molecules. The aim of 
this study was to identify a host ligand for S. aureus SdrD and to investigate the potential effect of this interaction 
on S. aureus colonization of host cells.
Results
sdrD gene localization and expression in S. aureus NCTC8325-4. The sdrD gene encodes LPXTG-
anchored protein of 1349 amino acids that is composed of an anterior A region (residues 36–568), a medial B 
region (residues 569–1123) and a posterior SD repeat R region (residues 1124–1289) (Fig. 1a). The sdr locus of S. 
aureus consists of sdrC, sdrD and/or sdrE, but may not all be present in the same strain6,7. From the annotation, 
the sdr locus of NCTC8325-4 contains sdrC and sdrD (Fig. 1b).
By allelic replacement, a NCTC8325-4ΔsdrD mutant was created. Bacterial growth was not significantly 
affected by deletion of sdrD (P < 0.05). Furthermore, both strains were haemolytic as visible on the blood agar 
plates (see supplementary Fig. S1). A heterologous expression system was constructed by expressing SdrD in the 
non-invasive bacterium L.lactis. Immunoblot analysis showed that the expression of SdrD was detected when 
sdrD gene was present in S. aureus and L.lactis (Fig. 1c, upper lane). The presence of bacterial lysate was proven 
by immunoblot of GroL (Fig. 1c, lower lane).
The expression pattern of sdrD in NCTC8325-4 was assayed in eukaryotic cell culture medium (DMEM sup-
plemented with FBS) in the absence or presence of HaCaT cells by use of a sdrD-specific GFP reporter construct. 
Immediately after inoculation, the expression of GFP showed a slight decrease, followed by an increase (Fig. 1d). 
The expression of the reporter was similar in the presence or absence HaCaT cells. Expression of SdrD in presence 
of HaCaT was detected in NCTC8325-4, but not in its isogenic mutant as confirmed by immunoblot (data not 
shown).
The presence of SdrD promotes adhesion of S. aureus in HaCaT cells. To investigate the contribu-
tion of SdrD in adherence to human keratinocytes, S. aureus NCTC8325-4 and the isogenic mutant NCTC8325-
4ΔsdrD were incubated with confluent layers of HaCaT cells. Unbound bacteria were removed by washing and 
adherent bacteria were quantified by plating serial dilutions. The presence of SdrD promoted better adherence of 
NCTC8325-4 to HaCaT cells, as the isogenic mutant showed two-fold reduction in adherence (P < 0.05) (Fig. 2a). 
S. aureus internalization into HaCaT cells has been demonstrated previously32,33. However, the internalized bac-
teria did not exceed 0.8% of the adhered bacteria (results not shown).
Figure 2. SdrD mediates adherence of S. aureus and L. lactis to HaCaT cells. Adherence of (a) S. aureus 
NCTC8325-4 and its isogenic mutant NCTC8325-4ΔsdrD and (b) L. lactis with pMG36e-sdrD (SdrD) or 
pMG36e (empty vector) to HaCaT cells. The number of inoculated bacteria was arbitrarily set as 100% and the 
number of attached bacteria represented as the mean percentage of inoculate. Data represent means ± SEM of 
4 independent experiments. Statistical analysis was performed by Student’s t-test. Significant differences are 
indicated by two (P < 0.01), or three (P < 0.001) asterisks (*).
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S. aureus expresses MSCRAMMs which might cause some functional redundancy in adherence assays8. 
Therefore, sdrD was cloned into a lactococcal vector (pMG36e) allowing heterologous expression in L. lactis. 
In adhesion assay performed using L. lactis, a significant increase was observed when L. lactis expressed SdrD 
compared to L. lactis carrying only empty vector (Fig. 2b). Through this approach, the redundancy challenges 
associated with S. aureus adhesins is avoided, and the effect of SdrD on bacterial adhesion could be observed. 
These results confirm that SdrD contributes to the S. aureus adhesion to HaCaT cells.
The presence of SdrD promotes S. aureus attachment to human desmoglein 1. To identify 
the host interaction partner within human skin, a yeast-two hybrid screen was performed using GAL4-SdrD 
A-region as bait in human reconstituted skin library. By this approach, desmoglein 1 (Dsg1) was identified as a 
putative interaction partner.
To assess Dsg1 as binding partner, we first studied the ability of SdrD to facilitate the adherence of S. aureus to 
Dsg1-coated microtiter plates. Wells were coated with Dsg1 Fc-chimera, IgG1 Fc or buffer only and the adherence 
of S. aureus NCTC8325-4 and its isogenic SdrD mutant were compared. S. aureus NCTC8325-4 adhered signif-
icantly better to immobilized Dsg1 than NCTC8325-4ΔsdrD (p < 0.05) (Fig. 3a). Similarly, when the amount of 
Dsg1 was raised from 0.1 to 1 μg/well, the bacterial adhesion was increased (Fig. 3b).
If bacteria expressing SdrD bind Dsg1 in solution, one would expect that the bacterium is coated with the 
protein and bind less efficiently to the immobilized Dsg1. Competition-based studies were performed where S. 
aureus NCTC8325-4 was pre-incubated with Dsg1, PBS or IgG1 Fc (the two latter as negative controls) before 
being allowed to adhere to immobilized Dsg1. As shown in Fig. 3c, pre-incubation of S. aureus NCTC8325-4 with 
Dsg1 considerably reduced its adhesion ability to immobilized Dsg1. This reduction in adherence was not seen 
or was much less when cells were pre-incubated with PBS or IgG1 Fc, respectively, thus showing that the binding 
between SdrD and Dsg1 is specific.
Finally, the interaction was evaluated using purified proteins. Thus, the microtiter plate was coated with two 
concentrations of immobilized GST-SdrD (A-region), prior to addition of recombinant Dsg1-protein. The bind-
ing of Dsg1 was thereafter evaluated using Dsg1-specific antibodies. As seen in Fig. 3d, recombinant Dsg-1 bound 
in a dose-dependent manner to immobilized SdrD (A region) protein. There was no significant binding between 
GST and Dsg1. All these results suggest a direct interaction between SdrD and Dsg1 in vitro.
Recombinant SdrD binds to HaCaT cells expressing Dsg1 and ectopic Dsg1 expression promotes 
SdrD-mediated S. aureus adhesion to HEK293 cells. HaCaT cells express Dsg1, which is predom-
inantly located in the upper layer of epidermis34. Expression of Dsg1 on the surface was confirmed by flow 
cytometry using Dsg1-specific antibody followed by detection with an Alexa-488 conjugated secondary antibody 
(Fig. 4a). To verify specificity of SdrD for Dsg1, recombinant full-length SdrD (see supplementary Fig. S2) were 
added to HaCaT cells and neutrophils. As shown in Fig. 4b, full length SdrD significantly bound to HaCaT cells 
expressing Dsg1 on their surface but not to neutrophils (Fig. 4c), which do not express Dsg123,35. On the other 
hand, S. aureus formyl peptide receptor inhibitor (FLIPr) bound neutrophils as expected36. Thus, SdrD specifi-
cally targets host cells expressing Dsg1.
Next, we assessed whether ectopic Dsg1 expression can promote S. aureus NCTC8325-4 adhesion to host 
cells. HEK293 cells were transfected with pcDNA3-Dsg1 (encoding Dsg1) or the control plasmid pcDNA3 and 
their binding to NCTC8325-4 or the isogenic NCTC8325-4ΔsdrD (negative control) was assessed. The number 
of adhered S. aureus NCTC8325-4 was significantly increased in HEK293 cells transfected with pcDNA3-Dsg1 
compared to HEK293 cells with the control plasmid pcDNA3 (Fig. 4d). Such an increase was not seen when 
assayed with the isogenic mutant (Fig. 4e). A direct comparison, using a five-fold increased MOI, confirmed that 
Dsg1 contributes in SdrD-mediated S. aureus attachment to the host cells (Supplementary Fig. S3).
Taken together, these results confirm that SdrD contributes significantly to adherence of S. aureus to host cells 
using Dsg1 as its interaction partner.
Discussion
Host adhesion molecules such as cadherins, integrins or immunoglobulin-related cell adhesion molecules 
(ICAMs) are connected to the host cytoskeleton, and are often used as targets for bacterial adhesion as well as 
internalization12. S. aureus binds specifically integrins through a fibronectin-bridge, while Haemophilus influen-
zae is an example of a bacterium that binds ICAMs. The EC1 domain of E-cadherin is a ligand for Listeria InlA12, 
while desmosomal cadherin Dsg2 is the receptor for Adenovirus37. In this study, we demonstrate for the first time 
that S. aureus SdrD interacts directly with Dsg1. The interaction was confirmed using several approaches includ-
ing yeast two hybrid (Hybrigenics) and ELISA based assays using purified recombinant SdrD and Dsg1 proteins. 
Additionally, disruption of sdrD in S. aureus NCTC8325-4 attenuated adhesion to immobilized Dsg1 and to 
human keratinocytes. However, there is a high functional redundancy among MSCRAMMs8. Since interaction 
with keratinocytes is not completely lost by deletion of SdrD, our data suggest that Dsg1 may also interact with 
other S. aureus adhesion molecules (Fig. 3a,b). Complementary, ectopic surface expression of Dsg1 in HEK293 
cells significantly increased adhesion of SdrD-expressing S. aureus and purified full-length SdrD protein binds 
to HaCaT cells that expressed Dsg1. All these results provide evidence for a direct interaction between SdrD and 
Dsg1, which improves bacterial adherence to keratinocytes.
Colonization is a well-known risk factor for development of staphylococcal infections, and adherence of 
S. aureus to the host cells promotes colonization38. The molecular aspects of colonization include interaction 
between bacterial adhesins and host molecules. Clumping factor B has recently been found to support coloni-
zation through its binding to loricrin39. Loricrin is highly expressed in stratum corneum40, and the interaction 
between loricrin and ClfB may be especially important in the initial phase of colonization. ClfB has previously 
also been found to interact with keratin 8 and 10 (reviewed in8), and cytokeratin 10 is expressed in the suprabasal 
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Figure 3. Dsg1 is a host ligand for SdrD. (a) S. aureus NCTC8325-4 and the isogenic mutant NCTC8325-
4ΔsdrD were added to wells coated with Dsg1-Fc chimera or control IgG1 Fc. Bacterial adherence was 
measured by staining with crystal violet and measurement of the absorbance at 570 nm. (b) Binding of S. 
aureus to Dsg1 is concentration dependent. Different concentrations of Dsg1 were coated on ELISA plates and 
bacterial adherence was evaluated as described in a. (c) S. aureus NCTC8325-4 was pre-incubated with IgG1 
Fc or Dsg1-Fc chimera and added to Dsg1-coated ELISA wells (1 μg/well). Bacterial adherence was evaluated 
as described in legend a. (d) Wells were coated with GST-SdrD-A region and GST before adding of Dsg1. 
Adherence of Dsg1 was determined using Dsg1-specific antibodies, followed by HRP-conjugated secondary 
antibody. The measurement of absorbance at 450 nm was carried out using an ELISA reader (VERSAmax, USA). 
The absorbance value for GST was arbitrarily 1 and the absorbance in presence of SdrD-A region is represented 
as fold change. Data represent means ± SEM of at least 3 independent experiments. Statistical analysis was 
performed by Student’s t-test. Significant differences are indicated by ns (no statistical significance), two 
(P < 0.01), three (P < 0.001) or four (P < 0.0001) asterisks (*).
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layer of epidermis41. Surprisingly, bacteria are present in all layers of human epidermis and even sub-epidermal 
compartment of human skin42, Here we have established that the SdrD–Dsg1 interaction promotes adhesion 
to keratinocytes. The desmosomal structure of which Dsg1 is part of, is connected to the keratins18, and it is 
tempting to speculate that both SdrD and ClfB may be of importance later during the colonization throught 
their interaction with Dsg1 and cytokeratin 10, respectively. However, although SdrD is shown to contribute to 
Figure 4. SdrD specifically binds and promotes S. aureus adherence to the host cells expressing Dsg1.  
(a) Dsg1 is expressed surface of HaCaT cells as measured by flow cytometry (blue histogram). Control antibody 
binding to cells in red histogram. (b) Binding of his-tagged SdrD (full length) to HaCaT cells as detected with 
anti-his-FITC by flow cytometry. The results are presented as geometric mean of the fluorescence intensity (FL). 
(c) Binding of his-tagged SdrD (full length) or FLIPr (positive control) to neutrophils measured as indicated in 
the figure legend b. (d) Ectopic expression of Dsg1 in HEK293 promotes adherence of NCTC8325-4 but  
(e) not NCTC8325-4ΔsdrD. The cells transfected with empty vector were arbitrarily set as 1, and the fold change 
of adherence in pcDNA3-Dsg1 transfected is represented as fold change. Data represent means ± SEM of at least 
3 independent experiments. Statistical analysis was performed by Student’s t-test. Significant differences are 
indicated by ns (no statistical significance), two (P < 0.01), or three (P < 0.001) asterisks (*).
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bacterial adhesion to human squamous cells isolated from the nose26, and its expression increases during nasal 
colonization43, it is not known whether SdrD-Dsg1 interaction promotes nasal colonization.
Keratinocytes constitute a large part of the epidermis44, and Dsg1 contributes to maintaining the structural 
epidermal integrity in stratified epidermal cells45. Dsg1 is targeted by S. aureus exfoliative toxin, resulting in 
loss of cell-cell adhesion in the epidermis46. Moreover, in the immune disease pemphigus, the tissue integrity is 
disrupted by autoantibodies against Dsg1/347. One hypothesis is that SdrD-Dsg1 interaction may also affect the 
structural integrity of the epidermis. However, subsequent molecular mechanism of this interaction remains to 
be investigated.
In addition, Dsg1 influences keratinocyte differentiation via its influence on the Ras intracellular signalling25. 
Thus, another hypothesis is that SdrD-Dsg1 interaction influences the ability of keratinocytes to effectively differ-
entiate into respective cellular structures within the epidermal-stratified structure. Dsg1 also influences the Rho 
signalling pathway48, an essential pathway affecting cytoskeleton and overall migration of cells49. This scenario 
could possibly influence the ability of S. aureus to invade deep tissues and subsequently enter into the blood-
stream. SdrD expression is regulated in the presence of whole human blood50. Thus this interaction might be 
essential for the invasion and subsequent migration of the bacterium from the site of colonization.
In conclusion, we have identified Dsg1 as a novel host ligand for S. aureus SdrD and demonstrated the impor-
tance of this interaction in the promotion of S.aureus adhesion to host cells. This interaction may initiate further 
biological processes, which could influence the pathogenesis and progression of S. aureus infections. A deeper 
understanding of the molecular mechanism of this interaction may aid in the development of anti-virulence 
strategies/therapeutics to combat S. aureus colonization of the epidermis.
Materials and Methods
Bacterial strains, mammalian cell lines and growth conditions. Staphylococcus aureus subsp. aureus 
NCTC8325-4 was used for allelic replacement and cloning of srdD for expression constructs. Lactococcus lactis 
MG1363 was used for heterologous expression assays51. S. aureus was cultured in tryptic soy broth (TSB) at 
37 °C with shaking at 220 rpm. L. lactis MG1363 was cultured in SMG17 (M17 broth supplemented with 0.5M 
sucrose (Sigma Aldrich, Germany) and 0.5% glucose (Sigma Aldrich, Germany) at 30 °C, without shaking. For 
adherence assays, overnight bacterial cultures were diluted 1:100 in appropriate culture medium and grown to 
OD600nm = 0.7–0.8 for S. aureus, and to OD600nm = 0.5–0.6 for L. lactis, before the bacteria were pelleted, washed 
twice in 1 × PBS (37 °C) and in DMEM media supplemented with 10% FBS.
HaCaT cells, a human keratinocyte cell line52 and HEK293 cells, a human embryonic kidney cell line, were 
purchased from PromoCell (Germany) and European collection of Cell Cultures (Porton Down, UK), respec-
tively. The cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma Aldrich, Germany), 
supplemented with 10% (v/v) fetal bovine serum (FBS) (Invitrogen Life Technologies, USA), penicillin (100 
units/ml), and streptomycin 100 μg/ml (Sigma Aldrich, Germany) in a CO2 incubator (5% CO2) at 37 °C.
Neutrophils were freshly isolated from heparinized venous blood of healthy volunteers (see section for ethical 
approval) using Histopaque (Sigma Aldrich, Germany)-Ficoll-paque (GE Healthcare, Sweden) gradient centrif-
ugation. Neutrophils were kept in RPMI 1640 (Gibco, Life Technologies, UK), supplemented with 0.05% human 
serum albumin (HSA) (Sanquin, Amsterdam, The Netherlands).
Genetic manipulation of S. aureus. Markerless precise allelic replacement of sdrD was performed in S. 
aureus NCTC8325-4 using previously described methods53 with minor modifications54. Briefly, DNA fragments 
1050 bp upstream and 1025 bp downstream of sdrD were amplified using primers Up For sdrD + attB1, Up Rev 
sdrD, Down For sdrD and Down Rev sdrD + attB2 (Table 1). The upstream and downstream PCR products were 
fused by PCR using Up For sdrD + attB1 and Down Rev sdrD + attB2 primers. The fusion construct was sub-
cloned into a temperature sensitive plasmid, pKOR155, using Gateway BP clonase II enzyme mix (Invitrogen, 
USA) and transformed into S. aureus NCTC8325-4 through electroporation. A temperature shifting and anti-
sense counter selection resulted in precise allelic replacement of sdrD. Deletion of sdrD was confirmed by PCR 
using primers sdrD KO confirm For + sdrD KO confirm Rev and sdrD Int For + sdrD Int Rev (Table 1), and by 
Western blot.
Heterologous expression of SdrD in L. lactis. For heterologous expression of SdrD in L. lactis MG1363, 
sdrD open reading frame from NCTC8325-4 genomic DNA was amplified using primers sdrD- pMG36e For 
and sdrD- pMG36e Rev (Table 1). The PCR product was digested using XbaI and XhoI, and ligated to the corre-
sponding sites of pMG36e56, yielding pMG36e-SdrD. pMG36e control or pMG36e-SdrD constructs were trans-
formed into L. lactis M1363 through electroporation (100-Ω resistance, 25 μF capacitance and 2.5 kV voltage). 
Transformants were selected and maintained in M17 medium (Oxoid, UK) containing 0.5% glucose and 10 μg/
ml erythromycin. The expression of SdrD in the transformed L.lactis M1363 was evaluated by Western blot using 
antibodies against the SdrD-A region (kind gift from Dr. Elisabet Josefsson).
Expression and purification of recombinant SdrD. Prokaryotic expression constructs for recombi-
nant SdrD were created as follows: The sdrD gene of S.aureus NCTC 8325-4 was amplified by PCR using either 
SdrD- Full length-F and SdrD- Full length-R or SdrD-A-F and SdrD-A-R (Table 1) primers. The PCR products 
with full-length or the A-region of SdrD were ligated to the corresponding sites of pRSETB vector (Invitrogen) or 
pGEX4T-1 (GE healthcare), respectively. Both plasmids were expressed in E. coli BL21 (DE3) and BL21, respec-
tively. Briefly, recombinant full-length SdrD was expressed upon overnight incubation at 20 °C using Luria broth 
(LB) media supplemented with ampicillin and glucose. IPTG was added to a final concentration of 1mM, and the 
induction occurred overnight. Recombinant full-length SdrD was purified from pRSETB-SdrD by Norwegian 
Structural Biology Center (http://norstruct.uit.no) using His Trap column. According to the company, the purity 
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of the full-length His-tagged SdrD protein is 85%. A selected fraction (supplementary Fig. S2, marked with red) 
was sent for mass spectrometry analysis and SdrD (gi 44685714) was detected as one of the protein hits (http://
www.matrixscience.com/cgi/master_results.pl?file= ..%2Fdata%2F20141209%2FFTgmOeamL.dat). GST-SdrD 
(A-region) was purified from pGEX4T-1-SdrD-A according to the manufacturer’s instructions.
Immunoblot. Immunoblot analysis was carried out on bacterial lysates. Cells of S. aureus and L. lactis were 
pelleted, dissolved in B-PER (Thermo Scientific, UK) and treated with 20 μg/ml lysostaphin (Sigma Aldrich, 
Germany) for 30 min at room temperature and 10 mg/ml lysozyme (Sigma Aldrich, Germany) for 1 hour at 37 °C, 
respectively. Bacterial lysates were freeze-thawed three times, followed by sonication. Aliquots of the bacterial 
lysates were used for western blot. The expression of SdrD was evaluated by immunoblot using antibodies against 
the SdrD-A region (kind gift from Dr. Elisabet Josefsson) as primary antibody and polyclonal Swine Anti Rabbit 
immunoglobulin (DAKO, Denmark) as secondary antibody. The GroL antibody (kind gift from Nikola Zlatkov 
Kolev ) was used as control.
sdrD expression in the absence and presence of eukaryotic cells. An sdrD-GFP -reporter construct 
was generated by amplifying the sdrD promoter region by PCR from genomic DNA of S. aureus NCTC8325-4 
using primers sdrD prom For and sdrD prom Rev (Table 1). The PCR product was ligated into the corresponding 
sites of pCM2957 upstream of GFP and transformed into S. aureus NCTC8325-4 by electroporation as previously 
described54. Expression of sdrD-GFP in S. aureus NCTC8325-4 was assessed in the absence or presence of HaCaT 
cells in DMEM supplemented with 10% FBS (without agitation). HaCaT cells were seeded at a density of 2 × 104 
cells/well into 96 wells microtiter plate (Corning, USA) in DMEM 10% FBS and infected with S. aureus sdrD-GFP 
reporter strain. For this purpose, an overnight culture of S. aureus NCTC8325-4 harbouring the sdrD-reporter 
construct was diluted 1:100 into pre-warmed tryptic soy broth (TSB, Sigma Aldrich, Germany), incubated at 
37 °C with agitation, and harvested at OD600nm = 0.7. The bacterial cells were pelleted, washed in phosphate saline 
buffer (PBS, pH 7.5), and diluted in DMEM 10% FBS. Fluorescence was measured using Synergy H1 Hybrid 
Reader (BioTek, USA) with excitation/emission of 488/520 nm. A control sample of non-transformed S. aureus 
NCTC8325-4 was included for background correction.
Yeast two-hybrid screen. A yeast-two hybrid service was ordered from Hybrigenics (http://www.
hybrigenics-services.com/). Briefly, GAL4-SdrD-A-region was used as bait in a human reconstituted skin library.
S. aureus NCTC8325-4 and NCTC8325-4ΔsdrD adherence and inhibition of binding to immo-
bilized recombinant Dsg1. Adherence of S. aureus NCTC8325-4 and S. aureus NCTC8325-4ΔsdrD to 
immobilized recombinant Dsg1 was principally evaluated as described previously39. Briefly, microtiter plates 
(Nunc, Denmark) were coated with coupling buffer (100 mM sodium carbonate (Sigma Aldrich, Germany), pH 
9.6) containing 1 μg/well recombinant human Dsg1-Fc chimera (R&D systems, USA) or Recombinant human 
IgG1 Fc (R&D systems, USA) and incubated overnight at 4 °C. Wells were blocked with 0.05% (w/v) bovine serum 
albumin (BSA) (Sigma Aldrich, Germany) for 2 h at 37 °C and washed with PBS supplemented with 0.05% (v/v) 
Tween (PBST). S. aureus NCTC8325-4 and NCTC8325-4ΔsdrD were grown overnight in TSB medium. The next 
Primers Sequence (5′- ′3) → Use Origin
Up For sdrD + attB1 GGGGACAAGTTTGTACAAAAAAGCAGGCTGACTCGGATAGCGACTCAGAC Generating fusion construct This work
Up Rev sdrD CAAGGACCTGGGTCATATTGTATAGATTACTCCTAAT TCATC Generating and sequencing fusion construct This work
Down For sdrD GATGAATTAGGAGTAATCTATACAATATG ACCCAGGTCCTT G Generating and sequencing fusion construct This work
Down Rev sdrD + attB2 GGGGACCACTTTGTACAAGAAAGCTGGGTCGTAGC CAACCGGAATATTG Generating fusion construct This work
pKOR1 For AGCTCCAGATCCATATCCTTC Sequencing fusion construct This work
pKOR1 Rev CACACAGGAAACAGCTATGAC Sequencing fusion construct This work
sdrD KO confirm For CGGTGGATTATTCGCGGC To confirm isogenic mutant This work
sdrD KO confirm Rev CACATTTTGAAGATATGCCGTGTTG To confirm isogenic mutant This work
sdrD Int For CGAGTGATAAAGTTGATATGCAGC To confirm isogenic mutant This work
sdrD Int Rev AGCCTCTGTTGATGATGGCTGTAC To confirm isogenic mutant This work
sdrD- prom For CGCCTGCAGCCAGGTCCATGTGGCCTGGTT Generating reporter construct This work
sdrD- prom Rev CGCGGTACCCAA ATT TTTAAATAATACAAT TGTTTTAAATACAAAAAT Generating reporter construct This work
sdrD- pMG36e For AAAATCTAGATGAATTAGGAGTAATCTAATGCT Generating heterologous construct This work
sdrD- pMG36e Rev TTCACTCGAGCGCCTCATATAAGTTTTATTCCGT Generating heterologous construct This work
Full Dsg1-F TAGTCCAAGCTTATGGACTGGAGTTTCTTC Generating eukaryotic expression construct of full length Dsg1 This work
Full Dsg1-R TTGTATGGATCCCTACTTGCTATATTGCAC Generating eukaryotic expression construct of full length Dsg1 This work
SdrD-A- F AACTGTCAAGGATTCTTAGTAGGTACAAC Amplification of SdrD-A region This work
SdrD-A-R ACGTAACGTAAGATCTTTAGGTTTGTAAATACC Amplification of SdrD-A region This work
SdrD- Full length-_F ATAGCGGCCGCTGTTTCTGGTAATGCTTTTGCTTTTGCTTTATTGTGATGG Amplification of full length SdrD This work
SdrD- Full length- R CGCGGATCCGCAGAAAGTACTAATAAAGAATTGAACGAA Amplification of full length SdrD This work
Table 1.  Primers used in this study.
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day, bacteria were diluted and grown to an OD600nm = 0.7–0.8 in TSB, washed in PBS, and suspended in PBS at 
OD600nm = 0.8–1. Thereafter, 100 μl of bacterial suspension was added to the Dsg1-coated or IgG1 Fc coated wells. 
The plates were incubated for 2 h at 37 °C, washed with PBST, and bound cells were fixed with paraformaldehyde 
(4% w/v) (Sigma Aldrich, Germany) for 20–30 min and stained with crystal violet (0.5% v/v, 100 μl per well) for 
1 min followed by PBS and acetic acid (5% v/v) washes. The absorbance was measured at 570 nm in an ELISA 
plate reader (VERSAmax, USA). Inhibition of S. aureus binding to immobilized recombinant Dsg1 was evalu-
ated as described previously39 by preincubating NCTC8325-4 and NCTC8325-4ΔsdrD with recombinant protein 
Dsg1-Fc (10 μg/ml), IgG1 Fc (10 μg/ml) or PBS for 30 min at room temperature.
Ligand binding assay. ELISA was used to analyse the ability of SdrD-A region to bind Dsg1 as described 
previously58 with minor modifications. Briefly, different concentrations of purified SdrD-A region were added 
to wells of a 96-well microtiter plate (Nunc) and the plate was incubated overnight at 4 °C. Wells were washed 
three times with PBS containing 0.05% Tween-20 (Sigma Aldrich, Germany), blocked with 0.05% or 1% (wt/vol) 
filter sterilized BSA in PBS for 2h at 37 °C. Wells were re-washed and Dsg1-Fc chimera (10 μg/ml) (R&D systems, 
USA) were added, and GST was used as a control. The adhered Dsg1 was determined using Dsg1471–499 antibodies 
(Abgent, USA), followed by HRP-conjugated polyclonal Swine Anti Rabbit immunoglobulin (DAKO, Denmark). 
The measurement of the absorbance at 450 nm was carried out in an ELISA reader (VERSAmax, USA).
Expression of Dsg1 on the surface of HaCaT cells. To detect the expression of Dsg1 on the sur-
face of HaCaT cells, HaCaT cells were incubated for 40 min at 4 °C with anti-Dsg1 antibodies (R&D systems, 
Minneapolis, MN), which is directed against the Dsg1 extracellular domain. After washing, cells were incubated 
for 30 min at 4 °C with the secondary antibody (Alexa 488® Donkey anti goat, Thermo scientific, UK). Flow 
cytometry analyses were performed using FACS Fortessa (BD Bioscience).
Binding of recombinant SdrD protein to eukaryotic cells. HaCaT cells were detached by treating 
with 1 × Citric Saline solution, thereafter fixed with 4% paraformaldehyde for 15 min. After washing, cells were 
blocked with 10% fetal bovine serum (FBS) in PBS for 15 min at room temperature. Cells were incubated for 
1 hour at 4 °C with 15 μg/ml SdrD in PBS supplemented with 5% FBS (Gibco, Life Technologies, UK). Human 
neutrophils were incubated on ice for 30 min at 4 °C with 14 μg/ml with full-length SdrD in RPMI/HSA or 10 ug/
mg FLIPr (S. aureus formyl peptide receptor inhibitor, a kind gift from Prof. Jos van Strijp). Bound his-tagged 
SdrD and FLIPr were detected using anti-his-FITC monoclonal antibody (LS Bio Sciences, USA/Abcam, UK). 
Flow cytometry was performed using BD Biosciences FACS Fortessa (HaCaT) and BD Bioscience FACS Calibur 
(Neutrophils). The fluorescence intensity (FL) of 10,000-gated cells was measured for each sample and geometric 
mean FL was calculated using FlowJo software (Flowjo, Ashland, OR).
Transfection. Human full-length Dsg1 in pLKpac was a kind gift from Dr Wahl59. The full-length dsg1 was 
amplified by PCR using primers Full Dsg1-F and Full Dsg1-R (Table 1), digested and sub-cloned into corre-
sponding BamHI/HindIII site of pcDNA3 (Invitrogen). The presence of dsg1 gene in the vector was confirmed 
by sequencing. HEK293 cells were seeded in 24-well plates at the concentration of 8.0–10.0 × 104 cells/well. After 
24 hours, transfection with pcDNA3-Dsg1 or control plasmid pcDNA3 was carried out using METAFECTENE® 
PRO (Biontex, USA) according to the manufacturer’s instructions. The total amount of DNA used in trans-
fection was kept constant by adding CT-DNA (Calf thymus DNA, Invitrogen, USA). A GFP reporter plasmid 
(pEGFP-C2) was used for monitoring transfection efficiency in each experiment. Transfection efficiency was 
routinely >80% for HEK293 cells.
Growth curves of S. aureus NCTC8325-4 and NCTC8325-4ΔsdrD. S. aureus NCTC8325-4 and 
NCTC8325-4ΔsdrD bacteria were grown overnight in Tryptic Soy Broth (TSB). The next day, bacteria were 
re-grown to OD600nm = 0.6 in TSB, washed, and resuspended in TSB or DMEM supplemented with 10% FCS 
(DMEM-FCS) at 1 × 105 CFU/ml. Bacteria dilutions were added to 100-well Bioscreen Honeycomb plates and 
growth was monitored by OD600nm measurements every 30 min under shaking conditions using Bioscreen C MBR 
machine at 37 °C.
Haemolytic activity of S. aureus NCTC8325-4 and NCTC8325-4ΔsdrD. S. aureus NCTC8325-4 
and NCTC8325-4ΔsdrD were streaked on the TSA plate containing 5% sheep blood and incubated overnight at 
37 °C to assess their haemolytic capacity after 18 hours. The plate was tranferred to 4 °C, and evaluated again after 
48 hours.
Adhesion assay. The adhesion assay was carried out in triplicate as previously described32. Briefly, HaCaT 
cells or HEK293 cells were seeded into 24-well plates at confluent concentration of approximately 1.3–1.5 × 105 
cells per well in DMEM 10% FBS. HEK293 cells were transfected with indicated plasmids. The day after, the pre-
pared bacterial strains were added to HaCaT cells and HEK293 cells at multiplicity of infection (MOI) 250 and 10 
or 50, respectively. The plates were incubated for 90 min at 37 °C in a 5% CO2–95% air atmosphere. Non-adhered 
bacterial cells were washed off, and the adhered bacteria were quantified by serial dilution plating after trypsiniz-
ing (trypsin-EDTA, Sigma Aldrich, Germany) and lysing of HaCaT cells using PBS containing 0.1% Triton X-100 
(Sigma Aldrich, Germany).
Ethical Approval. Human neutrophils were isolated from freshly drawn human blood in accordance with 
ethical principles of the Helsinki Declaration. The blood donors provided written informed consent, and the 
medical ethics committee of the University Medical Center Utrecht (Utrecht, The Netherlands) approved the 
used protocol.
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Statistical analysis. At least three biological replicates were done for the adhesion assays and ELISA-based 
experiments. The specific growth rate (k = ((log10 N − log10 N0) 2.303)/(t − t0)) of S. aureus NCTC8325-4 and 
NCTC8325-4ΔsdrD exponential phase were used to compare the growth of wild type versus isogenic mutant. 
Statistical analysis was carried out on the data of pooled experiments. Student’s t-test in Excel was used for deter-
mination of statistically significant differences between groups (P < 0.05). Excel was used for generating of graphs.
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